Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-21-010460
Filing Date
2021-04-30
Accepted
2021-04-30 16:28:54
Documents
2
Period of Report
2021-06-25

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dffn20210428_def14a.htm DEF 14A 505624
2 d01.jpg GRAPHIC 8156
  Complete submission text file 0001437749-21-010460.txt   518297
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37942 | Film No.: 21878564
SIC: 2834 Pharmaceutical Preparations